Tomotaka Shingaki

[Lymphocytic infundibulo-hypophysitis with diabetes insipidus as a new clinical entity: a case report and review of the literature].

Kanako Miyagi, Tomotaka Shingaki, Kazuko Ito et al. · PubMed · 1997 · 22 citations

Pituitary Mass, Diabetes Insipidus, Pituitary Gland +11

Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Takashi Kadowaki, Arihiro Kiyosue, Tomotaka Shingaki et al. · The Lancet Diabetes & Endocrinology · 2025 · 20 citations

Efficacy and safety of subgroup analysis stratified by baseline HbA1c in a Japanese phase 3 study of dulaglutide 0.75 mg compared with insulin glargine in patients with type 2 diabetes

Shizuka Kaneko, Tomonori Oura, Akiko Matsui et al. · Endocrine Journal · 2017 · 12 citations · Full text

Obesity, Metabolic Syndrome, Baseline Hba1c +11

Long-term safety and effectiveness of biosimilar insulin glargine in Japanese patients with diabetes mellitus in routine clinical practice: results of a post-marketing safety study

Tomotaka Shingaki, Kentaro Taki, Momoha Koyanagi et al. · Current Medical Research and Opinion · 2020 · 10 citations · Full text